医薬品用ゼラチン市場は、2030年までに6.4％のCAGRで成長し、15億9,580万ドルを超えると予想されます。医薬品用ゼラチンは、無色、水溶性、熱可逆性、生体適合性、半透明性、および高分子量の高感度素子です。コラーゲンの部分加水分解によって、動物の皮膚、白色結合組織、動物の骨から抽出されます。ゼラチンは、ハードカプセルやソフトジェルの製造における賦形剤として広く使用されています。また、錠剤の結合剤としても使用され、血漿代替物として利用されています。新田ゼラチン（日本）、Tessenderlo Group (ベルギー）、Gelita AG (ドイツ)など、さまざまなメーカーが世界中に医薬品ゼラチンを供給しています。たとえば、Darling Ingredients Inc.（米国）は、X-Pureなどの医薬品グレードのゼラチンをグローバルに提供しています。 X-Pureゼラチン、X-Pure GelMA、X-Pure GelDATなどのX-Pureシリーズは、ブタの皮膚から供給される高品質のゲル化および非ゲル化ゼラチンですそれは生物医学的用途の開発に関して重要な技術的利点になります。
医薬品の製造にゼラチンを使用する栄養補助食品や医薬品メーカーが世界的に増えていることから、医薬品用ゼラチン市場は予測期間中、大幅に拡大すると予想されます。さらに、ハードおよびソフトゲルカプセル、錠剤、ワクチンの製造のための医薬品用ゼラチンの用途の増加が、市場の成長を後押しします。また、慢性疾患の有病率の上昇、技術の進歩、ゼラチンカプセルシェルを製造するための製造コストの低さ、および栄養価の高い食品の消費についての意識の高まりが、予測期間中の市場の成長を促しています。
目次
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Techniques
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Impact on Supply Chain
5.3.3. Regional Impact
5.3.4. Opportunity and Threat Analysis
6. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY SOURCE
6.1. Overview
6.2. Porcine
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
6.3. Bovine Skin
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
6.4. Animal Bones
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
6.5. Others
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
7. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY FUNCTION
7.1. Overview
7.2. Stabilizer
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
7.3. Thickener
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
7.4. Gelling Agent
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
7.5. Others
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
8. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY APPLICATION
8.1. Overview
8.2. Hard Capsules
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
8.3. Soft Capsules
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
8.4. Micro-encapsulation
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
8.5. Coating for Tablets
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
8.6. Absorbable Hemostat
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
8.7. Others
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
9. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY TYPE
9.1. Overview
9.2. Type A
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
9.3. Type B
Market Estimates & Forecast, by Region, 2018-2030
Market Estimates & Forecast, by Country, 2018-2030
10. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. US
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. Italy
10.3.4. Spain
10.3.5. UK
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. Japan
10.4.2. China
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Rest of the World
10.5.1. Middle East
10.5.2. Africa
10.5.3. Latin America
11. COMPANY LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market Share Analysis
11.4. Major Growth Strategy in the Global Pharmaceutical Gelatin Market
11.5. Competitive Benchmarking
11.6. Leading Players in terms of Number of Developments in the Global Pharmaceutical Gelatin Market
11.7. Key Developments and Growth Strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial
11.8.1. Sales & Operating Income, 2021
11.8.2. Major Players R&D Expenditure, 2021
12. COMPANY PROFILES
12.1. Darling Ingredients Inc.
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Nitta Gelatin Inc.
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Tessenderlo Group
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. Gelita AG
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Weishardt International
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Trobas Gelatine B.V.
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Lonza Group AG
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Lapi Gelatine S.p.A
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Italgelatine S.p.A
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Xiamen Gelken Gelatin Co. Ltd.
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Gelco International
12.11.1. Company Overview
12.11.2. Financial Overview
12.11.3. Products Offered
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
12.12. Aspire Pharmaceuticals
12.12.1. Company Overview
12.12.2. Financial Overview
12.12.3. Products Offered
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.12.6. Key Strategies
12.13. India Gelatine & Chemicals Ltd.
12.13.1. Company Overview
12.13.2. Financial Overview
12.13.3. Products Offered
12.13.4. Key Developments
12.13.5. SWOT Analysis
12.13.6. Key Strategies
12.14. Gelnex Industria E Comercio Ltda
12.14.1. Company Overview
12.14.2. Financial Overview
12.14.3. Products Offered
12.14.4. Key Developments
12.14.5. SWOT Analysis
12.14.6. Key Strategies
12.15. Henan Boom Gelatin Co. Ltd
12.15.1. Company Overview
12.15.2. Financial Overview
12.15.3. Products Offered
12.15.4. Key Developments
12.15.5. SWOT Analysis
12.15.6. Key Strategies
12.16. Baotou Dongbao Bio-Tech Co. Ltd
12.16.1. Company Overview
12.16.2. Financial Overview
12.16.3. Products Offered
12.16.4. Key Developments
12.16.5. SWOT Analysis
12.16.6. Key Strategies
12.17. Norland Products Inc.
12.17.1. Company Overview
12.17.2. Financial Overview
12.17.3. Products Offered
12.17.4. Key Developments
12.17.5. SWOT Analysis
12.17.6. Key Strategies
12.18. Geltech Co. Ltd
12.18.1. Company Overview
12.18.2. Financial Overview
12.18.3. Products Offered
12.18.4. Key Developments
12.18.5. SWOT Analysis
12.18.6. Key Strategies
12.19. Geliko LLC
12.19.1. Company Overview
12.19.2. Financial Overview
12.19.3. Products Offered
12.19.4. Key Developments
12.19.5. SWOT Analysis
12.19.6. Key Strategies
12.20. Kenney & Ross Limited
12.20.1. Company Overview
12.20.2. Financial Overview
12.20.3. Products Offered
12.20.4. Key Developments
12.20.5. SWOT Analysis
12.20.6. Key Strategies
13. APPENDIX
13.1. References
13.2. Related Reports
?
LIST OF TABLES
TABLE 1 GLOBAL PHARMACEUTICAL GELATIN MARKET SYNOPSIS, 2018-2030
TABLE 2 GLOBAL PHARMACEUTICAL GELATIN MARKET ESTIMATES & FORECAST, 2018-2030 (USD MILLION)
TABLE 3 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 4 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 5 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 6 GLOBAL PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 8 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 9 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 10 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12 US: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 13 US: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 14 US: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 15 US: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 16 CANADA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 17 CANADA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 18 CANADA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 19 CANADA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 20 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 22 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 23 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24 EUROPE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 27 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 28 GERMANY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 30 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 31 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32 FRANCE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33 ITALY: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 34 ITALY: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 35 ITALY: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36 ITALY: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 39 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40 SPAIN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41 UK: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42 UK: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 43 UK: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44 UK: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 47 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48 REST OF EUROPE: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 51 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 52 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 55 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 56 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57 JAPAN: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 58 CHINA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 59 CHINA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 60 CHINA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61 CHINA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62 INDIA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 63 INDIA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 64 INDIA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65 INDIA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 67 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 68 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69 AUSTRALIA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 70 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 71 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 72 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73 SOUTH KOREA: PHARMACEUTICAL GELATIN MARKET, BY TYPE 2018-2030 (USD MILLION)
TABLE 74 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 75 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 76 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77 REST OF ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY REGION, 2018-2030 (USD MILLION)
TABLE 79 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 80 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 81 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 84 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 85 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86 MIDDLE EAST: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 88 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 89 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90 AFRICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 92 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 93 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94 LATIN AMERICA: PHARMACEUTICAL GELATIN MARKET, BY TYPE, 2018-2030 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL PHARMACEUTICAL GELATIN MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL PHARMACEUTICAL GELATIN MARKET
FIGURE 4 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY SOURCE, 2021
FIGURE 5 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY FUNCTION, 2021
FIGURE 6 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY APPLICATION, 2021
FIGURE 7 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY TYPE, 2021
FIGURE 8 GLOBAL PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021
FIGURE 9 NORTH AMERICA: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021
FIGURE 10 EUROPE: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021
FIGURE 11 ASIA-PACIFIC: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021
FIGURE 12 REST OF THE WORLD: PHARMACEUTICAL GELATIN MARKET SHARE (%), BY REGION, 2021
FIGURE 13 GLOBAL PHARMACEUTICAL GELATIN MARKET: COMPANY SHARE ANALYSIS (%), 2021
FIGURE 14 DARLING INGREDIENTS INC.: FINANCIAL OVERVIEW
FIGURE 15 DARLING INGREDIENTS INC.: SWOT ANALYSIS
FIGURE 16 NITTA GELATIN INC.: FINANCIAL OVERVIEW
FIGURE 17 NITTA GELATIN INC.: SWOT ANALYSIS
FIGURE 18 TESSENDERLO GROUP: FINANCIAL OVERVIEW
FIGURE 19 TESSENDERLO GROUP: SWOT ANALYSIS
FIGURE 20 GELITA AG: FINANCIAL OVERVIEW
FIGURE 21 GELITA AG: SWOT ANALYSIS
FIGURE 22 WEISHARDT INTERNATIONAL: FINANCIAL OVERVIEW
FIGURE 23 WEISHARDT INTERNATIONAL: SWOT ANALYSIS
FIGURE 24 TROBAS GELATINE B.V.: FINANCIAL OVERVIEW
FIGURE 25 TROBAS GELATINE B.V.: SWOT ANALYSIS
FIGURE 26 LONZA GROUP AG: FINANCIAL OVERVIEW
FIGURE 27 LONZA GROUP AG: SWOT ANALYSIS
FIGURE 28 LAPI GELATINE S.P.A: FINANCIAL OVERVIEW
FIGURE 29 LAPI GELATINE S.P.A: SWOT ANALYSIS
FIGURE 30 ITALGELATINE S.P.A: FINANCIAL OVERVIEW
FIGURE 31 ITALGELATINE S.P.A: SWOT ANALYSIS
FIGURE 32 XIAMEN GELKEN GELATIN CO. LTD.: FINANCIAL OVERVIEW
FIGURE 33 XIAMEN GELKEN GELATIN CO. LTD.: SWOT ANALYSIS
FIGURE 34 GELCO INTERNATIONAL: FINANCIAL OVERVIEW
FIGURE 35 GELCO INTERNATIONAL: SWOT ANALYSIS
FIGURE 36 ASPIRE PHARMACEUTICALS: FINANCIAL OVERVIEW
FIGURE 37 ASPIRE PHARMACEUTICALS: SWOT ANALYSIS
FIGURE 38 INDIA GELATINE & CHEMICALS LTD.: FINANCIAL OVERVIEW
FIGURE 39 INDIA GELATINE & CHEMICALS LTD.: SWOT ANALYSIS
FIGURE 40 GELNEX INDUSTRIA E COMERCIO LTDA: FINANCIAL OVERVIEW
FIGURE 41 GELNEX INDUSTRIA E COMERCIO LTDA: SWOT ANALYSIS
FIGURE 42 HENAN BOOM GELATIN CO. LTD: FINANCIAL OVERVIEW
FIGURE 43 HENAN BOOM GELATIN CO. LTD: SWOT ANALYSIS
FIGURE 44 BAOTOU DONGBAO BIO-TECH CO. LTD: FINANCIAL OVERVIEW
FIGURE 45 BAOTOU DONGBAO BIO-TECH CO. LTD: SWOT ANALYSIS
FIGURE 46 NORLAND PRODUCTS INC.: FINANCIAL OVERVIEW
FIGURE 47 NORLAND PRODUCTS INC.: SWOT ANALYSIS
FIGURE 48 GELTECH CO. LTD: FINANCIAL OVERVIEW
FIGURE 49 GELTECH CO. LTD: SWOT ANALYSIS
FIGURE 50 GELIKO LLC: FINANCIAL OVERVIEW
FIGURE 51 GELIKO LLC: SWOT ANALYSIS
FIGURE 52 KENNEY & ROSS LIMITED: FINANCIAL OVERVIEW
FIGURE 53 KENNEY & ROSS LIMITED: SWOT ANALYSIS
